Commonwealth Biotechnologies Moving Here

Commonwealth Biotechnologies, Inc. (CBI) has purchased approximately 4.8 acres in the Gateway Centre in Chesterfield. The company will construct a 30,000 square foot state-of-the-art facility. CBI currently employs 35 people at their location in the Virginia Biotechnology Research Park in Richmond. The expansion will create 30 new jobs over the next year-and-a-half.

“Once again, Virginia’s pro-business tax and reasonable regulatory policies have attracted further investment by a high-technology company, further securing our reputation as a high technology growth area,” said Governor Allen. “CBI’s decision to locate in Chesterfield increases Virginia’s presence in the biotechnology arena.”

CBI provides comprehensive analytical and synthetic chemistries to assist the biotechnology and pharmaceutical industries in their research efforts: including, but not limited to, high quality synthetic peptides and DNA/RNA/PNA, protein and DNA sequencing, amino acid analysis, mass spectrometry, calorimetry, and monoclonal and polyclonal antibodies. The company has been in the biotechnology industry for the past five years.

“This new facility will allow CBI to more effectively serve its existing client base and expand its capabilities to support the industry’s growth areas,” said Dr. Richard J. Freer, Chairman of CBI.

“We are delighted that Commonwealth Biotechnologies, Inc., is joining the growing list of corporations choosing Chesterfield County as their home. Chesterfield County wants to be the FIRST CHOICE business community, and CBI’s cutting-edge work in the field of biotechnology is a welcome addition to our county’s economic strength now and into the next century,” said Cheseterfield County Board of Supervisors Chairman Art Warren.